ISRCTN17435450已完成未知
Do oral corticosteroids provide clinical and cost-effective symptom relief for sore throat? A multicentre, double blind, randomized, placebo-controlled trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 510
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Male and female aged 18 years or above
- •2. Presenting to a primary care appointment with acute sore throat and odynophagia (pain on swallowing) which is judged by the clinician to be infective in origin
- •3. Onset of symptoms within the last 7 days
- •4. Patient has capacity and willingness, in the view of the recruiting clinician, to give consent and complete the trial paperwork, including the Symptom Diary
排除标准
- •1. Female participant who is pregnant, lactating or planning pregnancy during the course of the study
- •2. Recent (<1 month) use of inhaled or oral corticosteroids
- •3. Recent (<1 month) Adenotonsillectomy
- •4. Currently or recently (<14 days) taking antibiotics
- •5. Clear alternative diagnosis e.g. Pneumonia
- •6. Known immune-deficiency (e.g. HIV, active chemotherapy or advanced cancer)
- •7. Scheduled elective surgery or other procedures requiring general anaesthesia during next 7 days
- •8. Participant who is terminally ill
- •9. Symptoms or signs suggesting that hospital admission is required (e.g. Completely unable to swallow, very systemically unwell, peritonsillar abscess)
- •10. Participant judged by the GP to require immediate antibiotics
- •11. History of severe affective disorders including steroid-induced psychiatric illness
- •12. British National Formulary (BNF) listed contra-indications to oral steroids
- •13. Existing symptoms that are also side effects of, oral steroids
- •14. Patients taking other interacting medication (e.g. Phenytoin and anti-coagulants). Clinicians will be asked to use the BNF and their clinical prescribing systems to check for interactions for all patients
- •15. Known dexamethasone allergy
- •16. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant?s ability to participate in the study
- •17. Involvement in another clinical trial of an investigational medicinal product in the last 90 days or any other research within the last 30 days
- •18. Recruiting primary care site is not the patients usual practice if the patient is not expecting to still be with the primary care site in one month (i.e. Temporary residents)
- •19. Previous TOAST participation
- •20. Patients able to be randomised by the end of the (working) day of presentation
- •21. Requirement for live vaccine in next 7 days
研究者
相似试验
进行中（未招募）
不适用
Do oral corticosteroids provide clinical and cost-effective symptom relief for sore throat?EUCTR2012-004330-41-GBniversity of Oxford510
招募中
4 期
(Cost-)Effectiveness of local corticosteroid injection versus exercise therapy for shoulder complaints: a pragmatic randomized, 12 months comparative parallel-group trialshoulder complaintshoulder pain10023213NL-OMON52854Erasmus MC, Universitair Medisch Centrum Rotterdam808
尚未招募
不适用
SIX (Shoulder Injection and eXercise) trialNL-OMON22406Erasmus Medical Center, Department of General Practice213
招募中
不适用
The real-world oral corticosteroid burden in patients starting anti-interleukin-5 therapySevere eosinophilic astmaNL-OMON28832Medical Center Leeuwarden350
尚未招募
3 期
To compare the oral steroids versus intravenous steroids as a first line therapy for treatment of Acute severe ulcerative colitis.CTRI/2024/03/064590PGIMER